Venous Thromboembolism in Surgery
– A Preventable Complication
An Accredited CME Monograph Published as a Supplement to the American Journal of Surgery
|
|
||||||||
ACTIVITY OVERIVEW
Target Audience
This activity is designed for surgeons and other healthcare providers involved in the management of patients undergoing surgery.
Learning Objectives
- Identify and stratify risk factors for VTE in patients undergoing surgery.
- Describe the JCAHO/NQF and SCIP Quality Measures for the prevention of VTE.
- Describe the ACCP guideline recommendations and the importance of the continuity of care for VTE prophylaxis in surgical patients transitioning from inpatient to outpatient.
- Discuss the benefits, risks and economic implications of VTE prophylaxis.
Faculty
Joseph A. Caprini, MD, MS, FACS, RVT
Professor of Surgery, Feinberg School of Medicine
Professor of Biomedical Engineering , Robert R. McCormick School of Engineering and Applied Science
Northwestern University, Chicago, IL
Franklin A. Michota, MD, FACP
Associate Professor of Medicine
Director of Academic Affairs, Department of Hospital Medicine
Cleveland Clinic Lerner College of Medicine at Case Western University, Cleveland, OH
James E. Muntz, MD
Clinical Professor of Medicine & Associate Professor of Orthopedic Surgery
Baylor College of Medicine, Houston, TX
Marc A. Passman, MD
Associate Professor, Vascular Surgery
University of Alabama School of Medicine, Birmingham, AL
Independent Clinical Reviewer
Kenneth Wood, DO
Professor of Medicine and Anesthesiology
Senior Director of Medical Affairs
Director, Critical Care Medicine and Respiratory Care, The Trauma and Life Support Center
University of Wisconsin Hospital and Clinics Section of Pulmonary and Critical Care Medicine, Madison, WI
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and Horizon CME. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati designates this educational activity for a maximum of 2.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in this activity.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues which may arise as a result of prospective faculty members’ relevant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.
Faculty Disclosures
Faculty |
Disclosure(s) |
Joseph Caprini, MD |
Advisory Board – ConvaTech, Covidien, Eisai, sanofi-aventis |
James Muntz, MD |
Advisory Board - Bayer, Boehringer Ingelheim, sanofi-aventis, Johnson & Johnson |
Franklin Michota, Jr., MD |
Advisory Board – sanofi-aventis, Osaka Pharmaceuticals, Genentech and Ortho-McNeil/Johnson & Johnson |
Marc Passman, MD
|
No relevant relationships |
Off-Label Disclosure
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
No faculty member intends to reference off-label/unapproved uses of drugs or devices in their articles.
Disclaimer
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the participants’ professional development.
Planning Committee
The planning committee comprises Joseph Caprini, MD; James E. Muntz, MD; Franklin A. Michota, Jr, MD; Marc A. Passman, MD; Mary E. King, PhD; Kenneth Wood, DO; Brian Lee, PharmD; and Kay Weigand
Planning Committee Disclosures
All those involved in the planning and editing of this educational activity have disclosed that they have no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of this educational activity.
Commercial Acknowledgement
Supported by an educational grant from sanofi-aventis U.S.
Cost
There is no fee associated with this activity.
INSTRUCTIONS FOR PARTICIPATION
To be eligible for documentation of credit, participants must read all monograph content, complete the 10-question post-test with a score of 70% or better, and complete the evaluation questions. Participants who successfully complete the post-test and evaluation questions online may immediately print their documentation of credit.
You must log in to your account to take the Post-Test. If you do not currently have an account, please create an account.
Estimated time to complete: 2 hours
Release Date: January 1, 2010
Expiration Date: January 1, 2011
For questions regarding this educational activity, please contact Horizon CME at 503-775-5799.
Complete CME Post Test & Evaluation